GE Healthcare Technologies, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
2,768.00
2,581.00
2,361.00
2,512.00
2,875.00
2,710.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-357.00
-133.00
196.00
-95.00
-1,278.00
87.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
1,987.00
1,951.00
2,101.00
2,113.00
1,607.00
1,687.00
Cash Flow from Investing Activities
-1,047.00
-914.00
-558.00
-398.00
-1,761.00
19,986.00
Cash Flow from Financing Activities
617.00
-573.00
-478.00
-822.00
-263.00
-21,544.00
Net Cash Inflow / Outflow
1,623.00
387.00
1,055.00
890.00
-451.00
143.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
66.00
-77.00
-10.00
-3.00
-34.00
14.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of GE Healthcare Technologies, Inc.
Figures in Million
consolidated Cash Flow Results
Change(USD)
Change(%)
Profit Before Tax
2768
1435
1,333.00
92.89%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-357
-131
-226.00
-172.52%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
1987
1559
428.00
27.45%
Cash Flow from Investing Activities
-1047
-394
-653.00
-165.74%
Cash Flow from Financing Activities
617
-715
1,332.00
186.29%
Net Cash Inflow / Outflow
1623
459
1,164.00
253.59%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
66
9
57.00
633.33%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 1.85% vs -7.14% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
1,987.00
1,951.00
1.85%






